These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24469251)

  • 21. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
    Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
    Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
    Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
    Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of SCG10/stathmin-2 determines multipolar stage exit and neuronal migration rate.
    Westerlund N; Zdrojewska J; Padzik A; Komulainen E; Björkblom B; Rannikko E; Tararuk T; Garcia-Frigola C; Sandholm J; Nguyen L; Kallunki T; Courtney MJ; Coffey ET
    Nat Neurosci; 2011 Mar; 14(3):305-13. PubMed ID: 21297631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.
    Silva L; Harte-Hargrove L; Izenwasser S; Frank A; Wade D; Dow-Edwards D
    Neurosci Lett; 2015 Aug; 602():89-94. PubMed ID: 26118897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chronic low dose of Δ
    Bilkei-Gorzo A; Albayram O; Draffehn A; Michel K; Piyanova A; Oppenheimer H; Dvir-Ginzberg M; Rácz I; Ulas T; Imbeault S; Bab I; Schultze JL; Zimmer A
    Nat Med; 2017 Jun; 23(6):782-787. PubMed ID: 28481360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.
    Hoffman AF; Lupica CR
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23209160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure.
    de Salas-Quiroga A; García-Rincón D; Gómez-Domínguez D; Valero M; Simón-Sánchez S; Paraíso-Luna J; Aguareles J; Pujadas M; Muguruza C; Callado LF; Lutz B; Guzmán M; de la Prida LM; Galve-Roperh I
    Neuropsychopharmacology; 2020 Apr; 45(5):877-886. PubMed ID: 31982904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic regulation of SCG10 in regenerating axons after injury.
    Shin JE; Geisler S; DiAntonio A
    Exp Neurol; 2014 Feb; 252():1-11. PubMed ID: 24246279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.
    Viñals X; Moreno E; Lanfumey L; Cordomí A; Pastor A; de La Torre R; Gasperini P; Navarro G; Howell LA; Pardo L; Lluís C; Canela EI; McCormick PJ; Maldonado R; Robledo P
    PLoS Biol; 2015 Jul; 13(7):e1002194. PubMed ID: 26158621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection.
    Newton CA; Chou PJ; Perkins I; Klein TW
    J Neuroimmune Pharmacol; 2009 Mar; 4(1):92-102. PubMed ID: 18792785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
    Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
    J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ
    Beggiato S; Borelli AC; Tomasini MC; Morgano L; Antonelli T; Tanganelli S; Cuomo V; Ferraro L
    Neurobiol Learn Mem; 2017 Mar; 139():135-143. PubMed ID: 28104530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length.
    Tararuk T; Ostman N; Li W; Björkblom B; Padzik A; Zdrojewska J; Hongisto V; Herdegen T; Konopka W; Courtney MJ; Coffey ET
    J Cell Biol; 2006 Apr; 173(2):265-77. PubMed ID: 16618812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.
    Chen R; Zhang J; Fan N; Teng ZQ; Wu Y; Yang H; Tang YP; Sun H; Song Y; Chen C
    Cell; 2013 Nov; 155(5):1154-1165. PubMed ID: 24267894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of CB
    Joffre J; Yeh CC; Wong E; Thete M; Xu F; Zlatanova I; Lloyd E; Kobzik L; Legrand M; Hellman J
    J Immunol; 2020 Jun; 204(12):3339-3350. PubMed ID: 32385136
    [No Abstract]   [Full Text] [Related]  

  • 36. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.
    Karmaus PW; Chen W; Kaplan BL; Kaminski NE
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):843-55. PubMed ID: 21789506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
    Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
    J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ
    De Giacomo V; Ruehle S; Lutz B; Häring M; Remmers F
    Neuropharmacology; 2020 Nov; 179():108287. PubMed ID: 32860777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.